ABSTRACT
Alcohol engages signaling pathways in the brain. Midkine (MDK) is a neurotrophic factor that is over-expressed in the prefrontal cortex of alcoholics. MDK and one of its receptors, anaplastic lymphoma kinase (ALK), also regulate behavioral responses to ethanol in mice. The goal of this study was to determine whether MDK and ALK expression and signaling are activated by ethanol. We found that ethanol treatment of neuroblastoma cells increased MDK and ALK expression. We also assessed activation of ALK by ethanol in cells and found that ALK and ALK-dependent extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) phosphorylation increased rapidly with ethanol exposure. Similarly, treatment of cells with recombinant MDK protein increased ALK, ERK and STAT3 phosphorylation, suggesting that ethanol may utilize MDK to activate ALK signaling. In support of this, transfection of cells with MDK siRNAs attenuated ALK signaling in response to ethanol. Ethanol also activates ERK signaling in the brain. We found that inhibition of ALK or knockout of MDK attenuated ethanol-induced ERK phosphorylation in mouse amygdala. These results demonstrate that ethanol engages MDK and ALK signaling, which has important consequences for alcohol-induced neurotoxicity and the regulation of behaviors related to alcohol abuse.
Subject(s)
Brain/metabolism , Ethanol/pharmacology , Intercellular Signaling Peptides and Proteins/metabolism , Neuroblastoma/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction/physiology , Anaplastic Lymphoma Kinase , Animals , Brain/drug effects , Cell Line, Tumor , Enzyme Activation/drug effects , Enzyme Activation/physiology , Female , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Midkine , Signal Transduction/drug effectsABSTRACT
Long-term peritoneal dialysis induces peritoneal fibrosis with submesothelial fibrotic tissue. Although angiogenesis and inflammatory mediators are involved in peritoneal fibrosis, precise molecular mechanisms are undefined. To study this, we used microarray analysis and compared gene expression profiles of the peritoneum in control and chlorhexidine gluconate (CG)-induced peritoneal fibrosis mice. One of the 43 highly upregulated genes was pleiotrophin, a midkine family member, the expression of which was also upregulated by the solution used to treat mice by peritoneal dialysis. This growth factor was found in fibroblasts and mesothelial cells within the underlying submesothelial compact zones of mice, and in human peritoneal biopsy samples and peritoneal dialysate effluent. Recombinant pleiotrophin stimulated mitogenesis and migration of mouse mesothelial cells in culture. We found that in wild-type mice, CG treatment increased peritoneal permeability (measured by equilibration), increased mRNA expression of TGF-ß1, connective tissue growth factor and fibronectin, TNF-α and IL-1ß expression, and resulted in infiltration of CD3-positive T cells, and caused a high number of Ki-67-positive proliferating cells. All of these parameters were decreased in peritoneal tissues of CG-treated pleiotrophin-knockout mice. Thus, an upregulation of pleiotrophin appears to play a role in fibrosis and inflammation during peritoneal injury.
Subject(s)
Carrier Proteins/metabolism , Cytokines/metabolism , Gene Expression , Peritoneal Fibrosis/genetics , Peritoneal Fibrosis/metabolism , Peritoneum/pathology , RNA, Messenger/metabolism , Adult , Aged, 80 and over , Animals , Biopsy , CD3 Complex , Carrier Proteins/genetics , Carrier Proteins/pharmacology , Cell Movement/drug effects , Cells, Cultured , Chlorhexidine/analogs & derivatives , Connective Tissue Growth Factor/genetics , Cytokines/genetics , Cytokines/pharmacology , Dialysis Solutions/chemistry , Female , Fibronectins/genetics , Humans , Interleukin-1beta/metabolism , Ki-67 Antigen , Lymphocyte Count , Male , Mice , Middle Aged , Mitotic Index , Peritoneal Dialysis/adverse effects , Peritoneal Fibrosis/chemically induced , Peritoneal Fibrosis/physiopathology , Peritoneum/metabolism , Peritonitis/etiology , Peritonitis/metabolism , Permeability , T-Lymphocytes , Transforming Growth Factor beta1/genetics , Tumor Necrosis Factor-alpha/metabolism , Up-RegulationABSTRACT
There is considerable evidence showing that the neurodegenerative processes that lead to sporadic Parkinson's disease (PD) begin many years before the appearance of the characteristic motor symptoms and that impairments in olfactory, cognitive and motor functions are associated with time-dependent disruption of dopaminergic neurotransmission in different brain areas. Midkine is a 13-kDa retinoic acid-induced heparin-binding growth factor involved in many biological processes in the central nervous system such as cell migration, neurogenesis and tissue repair. The abnormal midkine expression may be associated with neurochemical dysfunction in the dopaminergic system and cognitive impairments in rodents. Here, we employed adult midkine knockout mice (Mdk(-/-)) to further investigate the relevance of midkine in dopaminergic neurotransmission and in olfactory, cognitive and motor functions. Mdk(/-) mice displayed pronounced impairments in their olfactory discrimination ability and short-term social recognition memory with no gross motor alterations. Moreover, the genetic deletion of midkine decreased the expression of the enzyme tyrosine hydroxylase in the substantia nigra reducing partially the levels of dopamine and its metabolites in the olfactory bulb and striatum of mice. These findings indicate that the genetic deletion of midkine causes a partial loss of dopaminergic neurons and depletion of dopamine, resulting in olfactory and memory deficits with no major motor impairments. Therefore, Mdk(-/-) mice may represent a promising animal model for the study of the early stages of PD and for testing new therapeutic strategies to restore sensorial and cognitive processes in PD.
Subject(s)
Cytokines/deficiency , Disease Models, Animal , Gene Deletion , Nerve Growth Factor/deficiency , Parkinson Disease/genetics , Parkinson Disease/pathology , Animals , Brain/pathology , Brain/physiology , Cytokines/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Midkine , Nerve Growth Factor/genetics , Parkinson Disease/metabolism , Recognition, Psychology/physiology , Smell/geneticsABSTRACT
BACKGROUND: Midkine is a heparin-binding cytokine involved in cell survival and various inflammatory processes. Midkine accumulates in senile plaques of patients with Alzheimer's disease, while it counteracts the cytotoxic effects of amyloid ß-peptide and inhibits its oligomerization. The present study was conducted to understand the role of midkine upon plaque formation of amyloid ß-peptide. METHODS: A surface plasmon assay was performed to determine the affinity of midkine for amyloid ß-peptide. The deposition of amyloid ß-peptide was compared in the brain of wild-type and midkine-deficient mice. An effect of midkine to microglias was examined by cell migration assay. RESULTS: Midkine bound to amyloid ß-peptide with the affinity of 160 nM. The C-terminal half bound to the peptide more strongly than the N-terminal half, and heparin inhibited midkine from binding to the peptide. Pleiotrophin, which has about 50% sequence identity with midkine also bound to amyloid ß-peptide. The deposition of amyloid ß-peptide plaques in the cortex and hippocampus was more intense in 15-month-old midkine-deficient mice, compared to the corresponding wild-type mice. Midkine promoted migration of microglias in culture. CONCLUSIONS: These results are consistent with the view that midkine attenuates the deposition of amyloid ß-peptide plaques, and thus progression of Alzheimer's disease, by direct binding and also by promoting migration of microglias.
ABSTRACT
OBJECTIVES: Midkine and Pleiotrophin are low molecular weight basic proteins with closely related structures and serve as growth/differentiation factors. They have been reported to be expressed in the cochlea during the embryonic and perinatal periods. In the present study, we focused on the roles of midkine and pleiotrophin in the stria vascularis and investigated morphological changes using mice deficient in these genes. METHODS: Midkine knockout, pleiotrophin knockout, and double knockout mice were used and compared to wild-type mice. Auditory brain stem responses (ABRs) and cochlear blood flows were measured in each type of mice. Pathological changes in the stria vascularis were examined by light microscopy, including immunohistochemical staining with anti-Kir4.1 antibody, and electron microscopy. RESULTS: Hearing thresholds examined by ABRs were significantly higher in midkine knockout and pleiotrophin knockout mice than in wild-type mice. Double knockout mice showed higher thresholds compared to midkine knockout and pleiotrophin knockout mice. Blood flow in the lateral walls did not significantly differ and light microscopy examination showed an almost normal appearance of the stria vascularis in these knockout mice. However, the expression of Kir4.1 was weak in the knockout mice and severe vacuolar degeneration was observed by electron microscopy in the intermediate cells of the double knockout mice. CONCLUSION: The present study demonstrates that midkine and pleiotrophin play some roles for the morphological maintenance of intermediate cell in the stria vascularis.
Subject(s)
Carrier Proteins/physiology , Cytokines/physiology , Stria Vascularis/pathology , Animals , Antibodies , Auditory Threshold/physiology , Cochlea/blood supply , Evoked Potentials, Auditory, Brain Stem , Immunohistochemistry , Mice , Mice, Knockout , Microscopy, Electron , Midkine , Potassium Channels, Inwardly Rectifying/analysisABSTRACT
BACKGROUND: Midkine is a heparin-binding cytokine and is involved in etiology of various diseases. Thus, midkine inhibitors are expected to be helpful in treatment of many diseases. METHODS: We developed a simple assay for midkine activity based on midkine-dependent migration of osteblastic cells. Midkine inhibitors were searched as materials that inhibit this midkine activity. To develop peptides that inhibit midkine activity, we constructed models in which C-terminal half of midkine interacted with alpha4beta1-integrin. Low molecular weight compounds which are expected to bind to midkine with high affinity were searched by in silico screening with the aid of Presto-X2 program. RESULTS: Among peptides in putative binding sites of midkine and the integrin, a peptide derived from beta1-integrin and that derived from the first beta sheet of the C-terminal half of midkine significantly inhibited midkine activity. Two low molecular weight compounds found by in silico screening exhibited no toxicity to target cells, but inhibited midkine activity. They are trifluoro compounds: one (PubChem 4603792) is 2-(2,6-dimethylpiperidin-1-yl)-4-thiophen-2-yl-6-(trifluoromethy)pyrimidine, and the other has a related structure. CONCLUSIONS: The assay procedure is helpful in screening midkine inhibitors. All reagents described here might become mother material to develop clinically effective midkine inhibitors.
ABSTRACT
Midkine (MK) is a growth factor implicated in the development and repair of various tissues, especially neural tissues. MK acts as a reparative neurotrophic factor in damaged peripheral nerves. A postulated role of MK in the degeneration and regeneration of sciatic nerves was explored by comparing wild-type (Mdk(+/+)) mice with MK-deficient (Mdk(-/-)) mice after freezing injury. In the Mdk(-/-) mice, a regenerative delay was observed, preceded by a decelerated Wallerian degeneration (WD). The relative wet weight of the soleus muscle slowly declined, and recovery was delayed compared with that in the Mdk(+/+) mice. In the regenerating nerve, unmyelinated axons were unevenly distributed, and some axons contained myelin-like, concentrically lamellated bodies. In the endplates of soleus muscles, nerve terminals containing synaptic vesicles disappeared in both mice. In Mdk(-/-) mice, the appearance of nerve terminals was delayed in synaptic vesicles of terminal buttons after injury. The recovery of evoked electromyogram was delayed in Mdk(-/-) mice compared with Mdk(+/+) mice. Our results suggested a delay in axonal degeneration and regeneration in Mdk(-/-) mice compared with Mdk(+/+) mice, and the delayed regeneration was associated with a delayed recovery of motor function. These findings show that a lack of MK following peripheral nerve injury is a critical factor in degeneration and regeneration, and manipulation of the supply of MK may offer interesting therapeutic options for the treatment of peripheral nerve damage.
Subject(s)
Cytokines/physiology , Nerve Regeneration/physiology , Sciatic Nerve/injuries , Wallerian Degeneration/physiopathology , Animals , Cytokines/deficiency , Cytokines/genetics , Electromyography , Freezing , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Midkine , Motor Endplate/ultrastructure , Muscle, Skeletal/innervation , Muscle, Skeletal/pathology , Nerve Fibers, Unmyelinated/pathology , Nerve Regeneration/genetics , Recovery of Function , Sciatic Nerve/metabolism , Wallerian Degeneration/geneticsABSTRACT
Midkine is a 13-kDa retinoic acid-induced heparin-binding growth factor involved in various biological phenomena such as cell migration, neurogenesis, and tissue repair. We previously demonstrated that midkine-deficient (Mdk(-/-)) mice exhibited a delayed hippocampal development with impaired working memory and increased anxiety only at the age of 4 weeks. To assess whether midkine gene could play important roles in development and maintenance of central nervous system, we investigated biochemical and behavioral parameters in dopamine and glutamate neurotransmission of Mdk(-/-) mice. The Mdk(-/-) mice exhibited a hypodopaminergic state (i.e., decreased levels of dopamine and its receptors in the striatum) with no alterations of glutamatergic system (i.e., normal level of glutamate, glutamine, glycine, d-serine, l-serine, and NMDA receptors in the frontal cortex and hippocampus). We also found prepulse inhibition deficits reversed by clozapine and haloperidol in the Mdk(-/-) mice. Our results suggested that midkine deficiency may be related to neurochemical and behavioral dysfunctions in dopaminergic system.
Subject(s)
Cytokines/deficiency , Dopamine/metabolism , Neural Inhibition/genetics , Reflex, Startle/genetics , Acoustic Stimulation/methods , Analysis of Variance , Animals , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid/methods , Dopamine Antagonists/metabolism , Dopamine Antagonists/pharmacology , Dopamine Plasma Membrane Transport Proteins/metabolism , Dose-Response Relationship, Drug , Exploratory Behavior/physiology , Interpersonal Relations , Mice , Mice, Inbred C57BL/metabolism , Mice, Inbred DBA/metabolism , Mice, Knockout , Midkine , Motor Activity/drug effects , Motor Activity/genetics , Neural Inhibition/drug effects , Protein Binding/drug effects , Protein Binding/genetics , Radioligand Assay/methods , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism , Reflex, Startle/drug effects , Tritium/metabolismABSTRACT
A significant proportion of cytokines bind to glycosaminoglycans such as heparin. Glycosaminoglycans are involved in signaling, stabilization and/or storage of these cytokines. Typical examples of glycosaminoglycan-binding cytokines are basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), VEGF-C, hepatocyte growth factor (HGF), granulocyte colony-stimulating factor (G-CSF), midkine, and pleiotrophin. All are present in the tumor microenvironment and promote tumor growth, tumor invasion and/or tumor angiogenesis. Serum or plasma levels of glycosaminoglycan-binding cytokines are frequently elevated in patients with various malignant tumors. High levels of these cytokines are usually correlated with the occurrence of metastasis and a poor prognosis. The mode of elevation of individual glycosaminoglycan-binding cytokines in patients with malignant tumors is summarized here. Further studies, especially with multiple cytokines, are expected to make assays clinically useful for both early detection and prognostic prediction.
Subject(s)
Biomarkers, Tumor/blood , Cytokines/blood , Glycosaminoglycans/metabolism , Biomarkers, Tumor/metabolism , Cytokines/metabolism , Fibroblast Growth Factor 2/blood , Fibroblast Growth Factor 2/metabolism , Humans , Interleukin-8/blood , Interleukin-8/metabolism , Neoplasms/blood , Neoplasms/diagnosis , Neoplasms/pathology , Protein Binding , Vascular Endothelial Growth Factor C/blood , Vascular Endothelial Growth Factor C/metabolismABSTRACT
CD4(+)CD25(+) regulatory T (Treg) cells are crucial mediators of autoimmune tolerance. The factors that regulate Treg cells, however, are largely unknown. Here, we show that deficiency in midkine (MK), a heparin-binding growth factor involved in oncogenesis, inflammation, and tissue repair, attenuated experimental autoimmune encephalomyelitis (EAE) because of an expansion of the Treg cell population in peripheral lymph nodes and decreased numbers of autoreactive T-helper type 1 (T(H)1) and T(H)17 cells. MK decreased the Treg cell population ex vivo in a dose-dependent manner by suppression of STAT5 phosphorylation that is essential for Foxp3 expression. Moreover, administration of anti-MK RNA aptamers significantly expanded the Treg cell population and alleviated EAE symptoms. These observations indicate that MK serves as a critical suppressor of Treg cell expansion, and inhibition of MK using RNA aptamers may provide an effective therapeutic strategy against autoimmune diseases, including multiple sclerosis.
Subject(s)
Cytokines/deficiency , Encephalomyelitis, Autoimmune, Experimental/prevention & control , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/immunology , Animals , Aptamers, Nucleotide/pharmacology , CD4 Antigens/immunology , Cell Proliferation/drug effects , Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/pathology , Forkhead Transcription Factors/immunology , Interleukin-2 Receptor alpha Subunit/immunology , Lymph Nodes/drug effects , Lymph Nodes/pathology , Mice , Mice, Inbred C57BL , Midkine , Myelin Proteins , Myelin-Associated Glycoprotein , Myelin-Oligodendrocyte Glycoprotein , Signal Transduction/drug effects , T-Lymphocytes, Helper-Inducer/cytology , T-Lymphocytes, Helper-Inducer/drug effects , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Regulatory/drug effectsABSTRACT
Embryoglycan is a class of branched high-molecular-weight poly-N-acetyllactosamines characteristically expressed in early embryonic cells and has been shown to be involved in the intercellular adhesion of early embryonic cells in vitro. Branching of poly-N-acetyllactosamine chains is performed by beta1,6-N-acetylglucosaminylation of the galactosyl residue. We previously knocked out the gene encoding I beta1, 6-N-acetylglucosaminyltransferase (IGnT), and the resultant deficient mice were born without any abnormality, although the mice exhibited various deficits in later life. In the present investigation, we produced embryonic stem (ES) cells from IGnT-deficient embryos. The mutant ES cells exhibited a reduced capability in embryoglycan synthesis. Thus, IGnT is a major enzyme involved in the branching of poly-N-acetyllactosamine chains in embryoglycan. Since ES cells are equivalent to multipotential cells of the embryonic ectoderm in early postimplantation embryos, this result indicates that an abundance of embryoglycan in these cells is not essential for normal embryogenesis. The IGnT-deficient ES cells continued to express SSEA-1, but lacked the expression of 4C9 antigen, although the epitope of 4C9 antigen was confirmed to be Lewis X by a transfection experiment. The result establishes the distinct nature of 4C9 antigenicity, which requires either Lewis X epitope on I-branch or clustering of Lewis X epitope, best accomplished by poly-N-acetyllactosamine branching. Alpha6-integrin was newly identified as a carrier of embryoglycan. The IGnT-deficient ES cells adhered to dishes coated with laminin, which is a ligand for alpha6-integrin, significantly less than wild-type ES cells, raising the possibility that embryoglycan in ES cells enhances alpha6-integrin-dependent adhesion in vitro.
Subject(s)
Embryonic Stem Cells/metabolism , Lewis X Antigen/metabolism , N-Acetylglucosaminyltransferases/deficiency , Polysaccharides/metabolism , Animals , Cell Adhesion/immunology , Cell Differentiation , Cell Line , Humans , Immunohistochemistry , Integrin alpha6/metabolism , Laminin/metabolism , Mice , Mice, Knockout , N-Acetylglucosaminyltransferases/genetics , N-Acetylglucosaminyltransferases/immunology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
OBJECTIVE: This study was to clarify the roles of midkine (MK) in the brain. METHODS: We determined cerebrospinal fluid MK levels in patients with neurological disorders by enzyme-linked immunoassay and immunostained autopsied brain samples in patients with meningitis. RESULTS: MK levels were 0.37+/-0.21 ng/ml in controls (n=46, mean +/- S.D.), 0.67+/-0.19 ng/ml in patients with cerebral infarction (n=8), 1.78+/-1.32 ng/ml in patients with meningitis (n=25; ANOVA and post-hoc Fisher's PLSD test, p<0.0001), 0.31+/-0.25 ng/ml in patients with human T-lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis (n=29), and 0.42+/-0.17 ng/ml in patients with amyotrophic lateral sclerosis (n=8). The regression equations were Y=0.005X+0.498 (Y, CSF MK level; X, cell number) and Y=0.007X+0.326 (Y, MK level; X, protein level) for all CSF samples. Autopsy brain samples from patients with meningitis expressed MK weakly in mononuclear cells on immunohistochemical examination. Western blot and polymerase chain reaction analyses showed that leukocytes were MK positive. CSF MK levels were not high in patients with cerebral infarction but were increased in patients with meningitis. CSF MK levels were high in normal controls, compared to those of other cytokines. MK was expressed in choroid plexus of normal brain and released there. CONCLUSION: Our findings suggested that MK may maintain normal adult brain as a neurotrophic factor, and that MK may be released from leucocytes in brain of patients with meningitis as an immunological mediator.
Subject(s)
Cerebral Infarction/metabolism , Cerebrospinal Fluid/chemistry , Choroid Plexus/metabolism , Cytokines/cerebrospinal fluid , Cytokines/metabolism , Meningitis/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Case-Control Studies , Female , Gene Expression Profiling , Humans , Immunohistochemistry , Male , Middle Aged , Midkine , RatsABSTRACT
There are many proteins that bind to proteoglycans; they include proteins in extracellular matrices, growth factors or cytokines, plasma proteins, transmembrane proteins, and cytoplasmic proteins as listed in this chapter. Proteins that bind to a proteoglycan have been searched by using a proteoglycan as a ligand. Alternatively, a ligand protein has been used to find a proteoglycan as a binding partner. When the glycosaminoglycan (GAG) portion of a proteoglycan is responsible for the binding, a native proteoglycan is necessary for the analysis of binding. When the protein portion is responsible for the binding, a recombinant core protein without GAG chains may be used for analysis. This chapter describes experimental procedures dealing with two native proteoglycans, versican (PG-M) and syndecan-4 (ryudocan). Versican has been identified as a proteoglycan with binding capability to a growth factor, midkine. Purified syndecan-4 has been used to identify proteins that bind to the proteoglycan.
Subject(s)
Proteins/chemistry , Syndecan-4/chemistry , Versicans/chemistry , Animals , Cells, Cultured , Cytokines/chemistry , Cytokines/isolation & purification , Cytokines/metabolism , Ligands , Mice , Midkine , Protein Binding , Proteins/analysis , Proteins/metabolism , Syndecan-4/metabolism , Versicans/metabolismABSTRACT
Midkine and pleiotrophin form a family of growth factors. Mice deficient in one of the genes show few abnormalities on reproduction and development. To understand their roles in these processes, we produced mice deficient in both genes; the double deficient mice were born in only one third the number expected by Mendelian segregation and 4 weeks after birth weighed about half as much as wild-type mice. Most of the female double deficient mice were infertile. In these mice, the numbers of mature follicles and of ova at ovulation were reduced compared to numbers in wild-type mice. Both midkine and pleiotrophin were expressed in the follicular epithelium and granulosa cells of the ovary. The expression of these factors in the uterus was dramatically altered during the estrous cycle. The diestrus and proestrus periods were long and the estrus period was short in the double deficient mice, indicating the role of the factors in the estrous cycle. Furthermore, vaginal abnormality was found in about half of the double deficient mice. These abnormalities in combination resulted in female infertility. Therefore, midkine and pleiotrophin, together with their signaling receptors, play important roles in the female reproductive system.
Subject(s)
Carrier Proteins/metabolism , Cytokines/deficiency , Cytokines/metabolism , Infertility, Female/etiology , Animals , Carrier Proteins/genetics , Crosses, Genetic , Cytokines/genetics , Female , Granulosa Cells/metabolism , Infertility, Female/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Midkine , Ovarian Follicle/metabolism , Vagina/abnormalitiesABSTRACT
Intraperitoneally administered chondroitin sulfate E inhibited the development of antibody-induced arthritis, a model of rheumatoid arthritis, while chondroitin 4-sulfate showed no effects. Chondroitin sulfate E inhibited in vitro differentiation of osteoclasts, which play key roles in the etiology of rheumatoid arthritis. One of the targets of chondroitin sulfate E is midkine, a heparin-binding growth factor or cytokine. Indeed, a chimeric-type siRNA for midkine inhibited the development of antibody-induced arthritis and adhesion of the omentum to the injured abdominal wall. These results indicate the significance of midkine as a molecular target to treat or prevent rheumatoid arthritis and adhesion after surgery, and the utility of chondroitin sulfate E to inhibit midkine in vivo.
Subject(s)
Arthritis, Rheumatoid/drug therapy , Chondroitin Sulfates/therapeutic use , Cytokines/antagonists & inhibitors , RNA, Small Interfering/therapeutic use , Animals , Antibodies/toxicity , Arthritis, Rheumatoid/immunology , Cell Differentiation/drug effects , Chondroitin Sulfates/administration & dosage , Cytokines/genetics , Disease Models, Animal , Female , Injections, Intraperitoneal , Mice , Mice, Inbred BALB C , Midkine , Osteoblasts/cytology , Osteoblasts/drug effects , RNA, Small Interfering/administration & dosageABSTRACT
BACKGROUND: Midkine is a heparin-binding growth factor preferentially expressed in tumor cells. The present study was performed to utilize anti-midkine antibody for tumor therapy. METHODS: A monoclonal antibody to midkine was raised by immunizing mice deficient in the midkine gene. The binding site of the antibody was studied by using N-terminal half and C-terminal half of midkine, both of which were chemically synthesized. Doxorubicin (DOX)-conjugate of the antibody was produced by chemical conjugation. The effects of the antibody and the conjugate on cell growth were examined using a midkine-secreting tumor cell, i.e. human hepatocellular carcinoma cell (HepG2). RESULTS: The monoclonal antibody bound to the N-terminal half of midkine. The antibody did not inhibit the growth of HepG2 cells probably because the active domain of midkine is in the C-terminal half. We produced the antibody conjugated with DOX with the hope that the conjugate would be internalized accompanied with midkine. Indeed, the antibody-DOX conjugate significantly inhibited the growth of HepG2 cells compared with DOX-conjugated control IgG. CONCLUSION: The result raises the possibility of using anti-midkine antibody conjugated with DOX for cancer therapy.
Subject(s)
Antibiotics, Antineoplastic/pharmacology , Carcinoma, Hepatocellular/pathology , Cytokines/immunology , Doxorubicin/pharmacology , Immunotoxins/pharmacology , Liver Neoplasms/pathology , Antibiotics, Antineoplastic/therapeutic use , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal/therapeutic use , Cell Survival/drug effects , Doxorubicin/therapeutic use , Humans , Immunotoxins/therapeutic use , Midkine , Tumor Cells, CulturedABSTRACT
alpha-Tectorin and beta-tectorin are major noncollagenous proteins of the tectorial membrane, which plays a crucial role in the reception of sonic signals in the cochlea. Midkine and pleiotrophin are closely related proteins that serve as growth factors and cytokines. In mice doubly deficient in the midkine gene and pleiotrophin gene, expression of beta-tectorin mRNA was nearly abolished in the cochlea on day 1 and 7 after birth. Expression of alpha-tectorin mRNA was unaffected in the double knockout mice, and expression of beta-tectorin mRNA was not altered in mice deficient in only the midkine or pleiotrophin gene. In newborn wild-type mice, both midkine and pleiotrophin were expressed in the greater epithelial ridge of the cochlea, in which beta-tectorin mRNA was strongly expressed. These results indicate that either midkine or pleiotrophin is required for significant expression of beta-tectorin. In agreement with the view that beta-tectorin is essential for normal auditory function, mice doubly deficient in both midkine and pleiotrophin genes exhibited very severe auditory deficits. We observed that mice deficient in either midkine or pleiotrophin gene were also impaired in their auditory response, but the level of the deficit was generally low or moderate. The present finding illustrates the importance of growth factor expression in the cochlea for auditory function.
Subject(s)
Cytokines/deficiency , Gene Expression Regulation, Developmental/physiology , Hearing/physiology , Tectorial Membrane/metabolism , Animals , Animals, Newborn , Auditory Threshold/physiology , Carrier Proteins/genetics , Cytokines/genetics , Evoked Potentials, Auditory, Brain Stem/physiology , Extracellular Matrix Proteins , Male , Membrane Proteins , Mice , Mice, Knockout , Midkine , RNA, Messenger/genetics , RNA, Messenger/metabolism , Tectorial Membrane/chemistryABSTRACT
Midkine, a heparin-binding growth factor, was found to be expressed in neural precursor cells, which consist of neural stem cells and the progenitor cells. When embryonic brain cells were allowed to form neurospheres enriched in neural precursor cells, numbers were significantly smaller from the midkine-deficient brain than from the wild-type brain. Dissociated neurosphere cells yielded nestin-positive neural precursor cells and differentiated neuronal cells upon culture on a substratum. Neural precursor cells from the midkine-deficient brain spread poorly and grew less effectively on a substratum coated with poly-l-lysine than the cells on midkine-coated substratum. Neural precursor cells from the wild-type brain spread and grew well on both the substrata. Differentiation to neurons and glia cells was not affected by the absence of midkine. Heparitinase digestion of dissociated neurosphere cells resulted in poor growth of neural precursor cells, while chondroitinase digestion had no effect. These results indicate that midkine is involved in the growth of neural precursor cells and suggest that the interaction with heparan sulfate proteoglycans is important in midkine action to these cells.
Subject(s)
Cytokines/pharmacology , Gene Expression/physiology , Neurons/drug effects , Stem Cells/drug effects , Animals , Brain/cytology , Cell Enlargement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Cytokines/deficiency , Cytokines/metabolism , Embryo, Mammalian , Female , Gene Expression Regulation/drug effects , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , In Situ Nick-End Labeling/methods , Intermediate Filament Proteins/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microtubule-Associated Proteins/metabolism , Midkine , Nerve Tissue Proteins/metabolism , Nestin , Pregnancy , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Time FactorsABSTRACT
Midkine is a heparin-binding growth factor and is expressed by a number of tumor cells, contributing to their growth both in vitro and in vivo. Spontaneous lung metastasis of Lewis lung carcinoma cells, which did not significantly express MK, was significantly less extensive in mice deficient in the midkine gene than in wild-type mice, when the tumor was subcutaneously grown above the thigh. Midkine strongly enhanced migration of Lewis lung carcinoma cells in vitro. Therefore, midkine is also a host factor enhancing tumor metastasis. Anti-midkine therapy for malignancy may act on midkine produced by both the tumor and host.
Subject(s)
Carcinoma, Lewis Lung/pathology , Cytokines/physiology , Lung Neoplasms/secondary , Animals , Cytokines/antagonists & inhibitors , Cytokines/genetics , Mice , Mice, Inbred C57BL , Midkine , Oligonucleotides, Antisense/therapeutic useABSTRACT
Ibeta6-N-acetylglucosaminyltransferase (IGnT) catalyzes the branching of poly-N-acetyllactosamine carbohydrate chains. In both humans and mice, three spliced forms of IGnT have been identified, and a common exon is present in all of them. We generated mice deficient in the common exon to understand the physiological function of poly-N-acetyllactosamine branching. IGnT activity was abolished in the stomach, kidney, bone marrow, and cerebellum of the deficient mice, while a low level of the activity persisted in the small intestine. Immunohistochemical analysis confirmed the loss of I antigen from the lung, stomach, and kidney. The deficient mice had reduced spontaneous locomotive activity. The number of peripheral blood lymphocytes was also reduced and renal function decreased in the deficient mice. Furthermore, in aged mice, vacuolization occurred in the kidney, and epidermoid cysts were frequently formed. However, cataracts did not develop earlier in the deficient mice. Decreased levels of lysosomal proteins, LAMP-2 and synaptotagmin VII, were found in the kidney of the deficient mice and correlated with renal abnormalities.